Efgartigimod alfa (Vyvgart) for Myasthenia Gravis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2022年 / 64卷 / 1648期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：62 / 63
页数：2
相关论文
共 50 条
  • [1] Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use
    Young-A Heo
    CNS Drugs, 2023, 37 : 467 - 473
  • [2] Efgartigimod alfa-the importance of FcRn blockade in the treatment of generalized myasthenia gravis
    Bozovsky, Tomas
    Ehler, Edvard
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2023, 86 (03) : 214 - 217
  • [3] Efgartigimod: A Review in Generalised Myasthenia Gravis
    Hannah A. Blair
    Drugs, 2024, 84 (11) : 1463 - 1474
  • [4] Efgartigimod in refractory autoimmune myasthenia gravis
    Remijn-Nelissen, Linda
    Tannemaat, Martijn R.
    Ruiter, Annabel M.
    Campman, Yvonne J. M.
    Verschuuren, Jan J. G. M.
    MUSCLE & NERVE, 2024,
  • [5] Efgartigimod is safe and effective in myasthenia gravis with sepsis
    Thakre, Mona
    Hussein, Mohamed
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [6] Efgartigimod improves triple-negative myasthenia gravis
    Frangiamore, Rita
    Rinaldi, Elena
    Vanoli, Fiammetta
    Andreetta, Francesca
    Mantegazza, Renato
    Antozzi, Carlo
    NEUROLOGICAL SCIENCES, 2024, 45 (03) : 1307 - 1309
  • [7] Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan
    Suzuki, Shigeaki
    Uzawa, Akiyuki
    Nagane, Yuriko
    Masuda, Masayuki
    Konno, Shingo
    Kubota, Tomoya
    Samukawa, Makoto
    Ishizuchi, Kei
    Tokuyasu, Daiki
    Handa, Hideo
    Yasuda, Manato
    Kawaguchi, Naoki
    Kimura, Takashi
    Suzuki, Yasushi
    Sugimoto, Takamichi
    Minami, Naoya
    Takahashi, Masanori P.
    Murai, Hiroyuki
    Utsugisawa, Kimiaki
    NEUROLOGY-CLINICAL PRACTICE, 2024, 14 (03)
  • [8] Efgartigimod in Myasthenia Gravis: Phase 3 Trial Design
    Howard, J. F., Jr.
    De Haard, H.
    Parys, W.
    Ulrichts, P.
    Guglietta, A.
    Mantegazza, R. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 353 - 353
  • [9] Efgartigimod A novel antibody depletion therapy in myasthenia gravis
    Guidon, Amanda C.
    Juel, Vern C.
    NEUROLOGY, 2019, 92 (23) : 1079 - 1080
  • [10] Efgartigimod improves triple-negative myasthenia gravis
    Rita Frangiamore
    Elena Rinaldi
    Fiammetta Vanoli
    Francesca Andreetta
    Renato Mantegazza
    Carlo Antozzi
    Neurological Sciences, 2024, 45 : 1307 - 1309
12345